drugset / Trial / NCT02860858
Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV)
NaSingle-groupOpen-labelTreatment
Summary
Objective: To evaluate the efficacy of intravitreal aflibercept injection on visual acuity in patients with symptomatic macular PCV.
Timeline
- Start
- 2016-12-30
- Primary completion
- 2018-08-30
- Completion
- 2018-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aflibercept | Protein / enzyme biologic | — | Intravitreal |
Indications
No indication recorded.